Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of ... 
MarketWatch (press release)
Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the US Pfizer has ...

and more » 

BioSpecifics Technologies Corp. Announces Initiation of Phase II Trial for ... 
MarketWatch (press release)
Today, injectable collagenase, registered as XIAFLEX®, is marketed in the US for the treatment of Dupuytren's contracture in adults with a palpable cord by the Company's partner Auxilium Pharmaceuticals, Inc. (Auxilium) and is marketed in Europe under ...

and more » 

Doctor brings groundbreaking surgery back to Boise 
KIVI-TV
By Roland Beres Imagine a disease that causes your fingers to curl permanently. It's called Dupuytren's Contracture and it affects close to 30 percent of the Caucasian population. Surgery to fix it is expensive, risky and requires long rehab.

and more » 

Local doctor offers new treatment for crippling condition 
Summit Daily News
Dr. Erik Dorf treats Vic Hauser, who suffers from Dupuytren's Disease, with Xiaflex while physician assistant Annie Bowen looks on. Unless you're among the 3-6 percent who suffer from Dupuytren's Disease, there's a good chance you've never heard of ...

 

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 
Sacramento Bee
On February 23, 2012, Auxilium entered into a collaboration agreement with Actelion Pharmaceuticals Ltd for the development and commercialization of XIAFLEX for the treatment of Dupuytren's contracture and Peyronie's disease in Australia, Brazil, ...

and more » 

BioSpecifics Technologies Corp. to Host Conference Call to Report First ... 
MarketWatch (press release)
Today, injectable collagenase, registered XIAFLEX®, is marketed in the US for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm by the Company's partner Auxilium Pharmaceuticals, Inc. (Auxilium) and is marketed in ...

and more » 

BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 ... 
PR Newswire (press release)
Today, injectable collagenase, registered as XIAFLEX ® , is marketed in the US for the treatment of Dupuytren's contracture in adults with a palpable cord by the Company's partner Auxilium Pharmaceuticals, Inc. (Auxilium) and is marketed in Europe ...

and more » 

Full Report: New cure for Viking hand disease 
ITV News
Sufferers of a disease which has been passed down from the Vikings have been given fresh hope with the development of a new treatment. Dupuytren's Disease affects the hands. It causes an abnormal thickening of the tissue just beneath the skin.

 

Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care ... 
MarketWatch (press release)
Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in the US and XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord.
BioSpecifics Technologies Corp. Reports First Quarter 2012 Financial Results Sacramento Bee

all 22 news articles » 

Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct ... 
MarketWatch (press release)
Auxilium markets Testim® 1% (testosterone gel) for the topical treatment of hypogonadism in the US and XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord.

and more »